FDA Adverse Event Injury Summary report: N

ZIO XT DTP - UKCA

MDR report key: 23154089 · Received September 26, 2025

Report

Report Number
3007208829-2025-00214
Event Type
Injury
Date Received
September 26, 2025
Date of Event
September 3, 2025
Report Date
September 26, 2025
Manufacturer
IRHYTHM TECHNOLOGIES, INC
Product Code
DSH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

A REVIEW OF THE COMPLAINT REVEALED THAT THE PATIENT WORE THE ZIO XT DEVICE FOR 5 OF THE 14 DAYS PRESCRIBED. THE PATIENT HAS SENSITIVE SKIN BUT DOES NOT HAVE A HISTORY OF REACTIONS TO MEDICAL ADHESIVE. THE EXACT CAUSE OF THE REPORTED EVENT CANNOT BE DETERMINED; HOWEVER, THE PATIENT¿S PREEXISTING SENSITIVITY CANNOT BE RULED OUT AS A CONTRIBUTORY FACTOR. THE ZIO XT CLINICAL REFERENCE MANUAL THAT IS DISTRIBUTED IN THE UNITED KINGDOM PROVIDES A WARNING THAT STATES, ¿PRIOR TO MONITOR APPLICATION, EXAMINE THE SKIN AREA OF THE PATIENT FOR CERTAIN SKIN CONDITIONS (SUCH AS DERMATITIS, ECZEMA, RASHES/HIVES), ACUTE/CHRONIC CUTANEOUS INFECTIONS OR IRRITATION. IF SKIN IRRITATION SUCH AS SEVERE REDNESS." THIS EVENT IS BEING REPORTED PER 21CFR803 AS A SERIOUS INJURY. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY RHYTHM THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY DEFECTS OR HAS MALFUNCTIONED. THESE TERMS ARE INCLUDED IN FORM FDA 3500A AND ARE FIXED TERMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING.

Description of Event or Problem · 0

THE PATIENT PRESENTED TO THEIR HEALTHCARE PROVIDER (HCP) WITH SIGNS OF AN ALLERGIC REACTION ALLEGEDLY CAUSED BY THE ZIO XT. THE PATIENT REPORTED SYMPTOMS OF ITCHING, REDNESS, BLISTERS AND HIVES. THE DEVICE WAS REMOVED, AND THE HCP PRESCRIBED FEXOFENADINE & PREDNISOLONE AS TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2111810 ZIO XT DTP - UKCA RECORDER, MAGNETIC TAPE, MEDICAL DSH IRHYTHM TECHNOLOGIES, INC

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention